Integrity Capital Management (HK)’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

Integrity Capital Management (HK)’s Portfolio MTACU Stock Details MTACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,700	Closed	-$46K	–	72
2022 Q1	$46K	Buy	+4,700	New	+$46.7K	0.24%	87

Other funds holding MTACU

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Integrity Capital Management (HK)'s MTACU Position: Q2 2022 in Review

Integrity Capital Management (HK) sold out of MedTech Acquisition Corporation Unit (MTACU) in Q2 2022, closing a stake of 4,700 shares — an estimated $46K sold.

Integrity Capital Management (HK) first reported a position in MTACU in Q1 2022 and held it in 1 quarter. The position peaked at $46K in Q1 2022. 4 funds tracked by Wall St. Rank hold MTACU as of Q2 2022.

Integrity Capital Management (HK) reported no remaining MedTech Acquisition Corporation Unit position as of Q2 2022 after selling out during the quarter.
Integrity Capital Management (HK) sold 4,700 MedTech Acquisition Corporation Unit shares in Q2 2022, an estimated $46K.
Integrity Capital Management (HK) first reported a position in MedTech Acquisition Corporation Unit in Q1 2022 and held it in 1 quarter.
Integrity Capital Management (HK)'s MedTech Acquisition Corporation Unit position peaked at $46K in Q1 2022.
4 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q2 2022.

Based on Integrity Capital Management (HK)'s 13F filing for Q2 2022, filed 28 Jul 2022.